2nd University Department of Cardiology, Attikon General Hospital, Athens, Greece.
Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.
Beta-thalassemia major is a unique disease characterized by early diastolic dysfunction, related exclusively to iron myocardial deposition. N-terminal-proBNP(amino-terminal) (NT-proBNP) and B-type natriuretic peptide (BNP) are sensitive biomarkers for the detection of asymptomatic left ventricular (LV) dysfunction, and they have important diagnostic and prognostic implications. Using beta-thalassemia as a model disease with isolated diastolic dysfunction, we sought to investigate the predictive value of NT-proBNP and BNP levels in comparison with the conventional and new Doppler echocardiography indexes in detecting this disorder.
Seventy beta-thalassemia major patients (mean age 27.2 +/- 12.5 years) with normal LV systolic function (mean LV ejection fraction = 59% +/- 6.8%), and 50 healthy age-matched adults (control group: mean age 25.5 +/- 10.1 years, mean LV ejection fraction = 60% +/- 4.5%) were included. All subjects were studied thoroughly by tissue Doppler echocardiography and blood samples were taken for plasma NT-proBNP and BNP measurements at the same time. To examine LV diastolic function, patients were divided in 3 groups according to the E mitral/E mitral annulus ratio (E/E'): group A, patients without diastolic dysfunction: E/E' ratio <8; group B, patients with suspected diastolic dysfunction: E/E' ratio 8 to 15; group C, patients with documented diastolic dysfunction: E/E' ratio, >15.
NT-proBNP and BNP levels were higher in thalassemic patients compared with the control group (NT-proBNP levels: 80 +/- 19 vs 21 +/- 4 pg/mL, P < .001; BNP levels: 34 +/- 6 vs 9 +/- 3 pg/mL, P < .001). NT-proBNP levels showed a statistically significant increase in group C in comparison to groups A and B, which was also detected between groups A and B (A vs B: P < .05). BNP levels were also significantly increased in group C in comparison to the other 2 groups, but there was no statistically significant difference between groups A and B. Using receiver operating characteristic analysis, NT-proBNP at a cut point of 49.2 pg/mL was highly accurate (area under curve: 0.97, P < .001) in ruling out diastolic dysfunction (E/E' <8) with a sensitivity of 93.7% and a specificity of 89.6%.
BNP and NT-proBNP levels are significantly increased in documented left ventricular diastolic dysfunction, while NT-proBNP seems to have better predictive value in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
β-地中海贫血主要是一种独特的疾病,其特征为舒张早期功能障碍,仅与铁心肌沉积有关。氨基末端脑钠肽前体(N 末端-proBNP)(NT-proBNP)和 B 型利钠肽(BNP)是检测无症状左心室(LV)功能障碍的敏感生物标志物,具有重要的诊断和预后意义。使用β-地中海贫血作为孤立性舒张功能障碍的模型疾病,我们试图研究 NT-proBNP 和 BNP 水平与常规和新的多普勒超声心动图指标在检测这种障碍方面的预测价值。
70 例β-地中海贫血主要患者(平均年龄 27.2 ± 12.5 岁),LV 收缩功能正常(平均 LV 射血分数=59%±6.8%),50 例年龄匹配的健康成年人(对照组:平均年龄 25.5 ± 10.1 岁,平均 LV 射血分数=60%±4.5%)。所有受试者均进行组织多普勒超声心动图全面检查,并同时采集血浆 NT-proBNP 和 BNP 测量值的血样。为了检查 LV 舒张功能,根据 E 尖瓣/E 尖瓣环比(E/E')将患者分为 3 组:A 组,无舒张功能障碍患者:E/E'比<8;B 组,疑似舒张功能障碍患者:E/E'比 8 至 15;C 组,有记录的舒张功能障碍患者:E/E'比>15。
与对照组相比,地中海贫血患者的 NT-proBNP 和 BNP 水平较高(NT-proBNP 水平:80±19 与 21±4 pg/mL,P<0.001;BNP 水平:34±6 与 9±3 pg/mL,P<0.001)。与 A 组和 B 组相比,C 组的 NT-proBNP 水平呈统计学显著增加,A 组和 B 组之间也检测到 NT-proBNP 水平增加(A 与 B:P<0.05)。与其他 2 组相比,BNP 水平在 C 组中也显著增加,但 A 组和 B 组之间无统计学差异。使用受试者工作特征分析,NT-proBNP 截断值为 49.2 pg/mL 时对排除舒张功能障碍(E/E'<8)具有高度准确性(曲线下面积:0.97,P<0.001),敏感性为 93.7%,特异性为 89.6%。
在有记录的左心室舒张功能障碍中,BNP 和 NT-proBNP 水平显著增加,而 NT-proBNP 似乎在检测β-地中海贫血患者的潜在左心室舒张功能障碍方面具有更好的预测价值。